Results 141 to 150 of about 965,812 (155)

Emerging drugs for the treatment of chronic myelomonocytic leukemia

Expert Opinion on Emerging Drugs, 2020
Guillermo Montalban-Bravo
exaly  

Results of Topotecan Single-Agent Therapy in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Leukemia and Lymphoma, 1998
Elihu Estey, Hagop Kantarjian, Steven Kornblau   +2 more
exaly  

[Induction of differentiation of human myelomonocytic cell lines by chemical inducers: analysis of surface antigens with monoclonal antibodies].

Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society, 1984
K, Yamada, N, Okabe, H, Saito, R, Suzuki
openaire   +1 more source

JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemia

British Journal of Haematology, 2005
Muhammad Farid Johan, Anne Goodeve
exaly  

Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations

British Journal of Haematology, 2010
Hideki Muramatsu, Anna M Jankowska
exaly  

Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia

Modern Pathology, 2013
Alona Muzikansky, Amir Fathi, Attilio Orazi   +2 more
exaly  

Prognostic factors and risk assessment in chronic myelomonocytic leukemia: Validation study of the M.D. Anderson Prognostic Scoring System

Leukemia and Lymphoma, 2007
Jaroslav Jelínek, Francesco Onida, Yu Shen   +2 more
exaly  

Myelomonocytic Antigens are Rarely Expressed on B-Lymphocytic Leukemia Cells

Leukemia and Lymphoma, 1993
Michael Schlesinger, Ruth Rabinowitz, A Polliack   +2 more
exaly  

New prognostic parameters for chronic myelomonocytic leukemia?

Blood, 2002
exaly  

Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: A case series and literature review

Leukemia Research, 2012
Filipa Moita, Antonio Almeida, Francesca Pierdomenico   +2 more
exaly